JP2007269797A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007269797A5 JP2007269797A5 JP2007121321A JP2007121321A JP2007269797A5 JP 2007269797 A5 JP2007269797 A5 JP 2007269797A5 JP 2007121321 A JP2007121321 A JP 2007121321A JP 2007121321 A JP2007121321 A JP 2007121321A JP 2007269797 A5 JP2007269797 A5 JP 2007269797A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- ester
- acceptable salt
- compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/998,877 | 1997-12-24 | ||
US08/998,877 US6054446A (en) | 1997-12-24 | 1997-12-24 | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006271307A Division JP3968114B2 (ja) | 1997-12-24 | 2006-10-02 | 新規な抗エストロゲンステロイド、ならびに関連の薬学的組成物および使用法 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2007269797A JP2007269797A (ja) | 2007-10-18 |
JP2007269797A5 true JP2007269797A5 (pt-PT) | 2009-10-01 |
JP4718512B2 JP4718512B2 (ja) | 2011-07-06 |
Family
ID=25545637
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53517299A Withdrawn JP2001525855A (ja) | 1997-12-24 | 1998-12-23 | 新規な抗エストロゲンステロイド、ならびに関連の薬学的組成物および使用法 |
JP2006271306A Expired - Lifetime JP4959276B2 (ja) | 1997-12-24 | 2006-10-02 | 新規な抗エストロゲンステロイド、ならびに関連の薬学的組成物および使用法 |
JP2006271307A Expired - Fee Related JP3968114B2 (ja) | 1997-12-24 | 2006-10-02 | 新規な抗エストロゲンステロイド、ならびに関連の薬学的組成物および使用法 |
JP2007121321A Expired - Lifetime JP4718512B2 (ja) | 1997-12-24 | 2007-05-01 | 新規な抗エストロゲンステロイド、ならびに関連の薬学的組成物および使用法 |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53517299A Withdrawn JP2001525855A (ja) | 1997-12-24 | 1998-12-23 | 新規な抗エストロゲンステロイド、ならびに関連の薬学的組成物および使用法 |
JP2006271306A Expired - Lifetime JP4959276B2 (ja) | 1997-12-24 | 2006-10-02 | 新規な抗エストロゲンステロイド、ならびに関連の薬学的組成物および使用法 |
JP2006271307A Expired - Fee Related JP3968114B2 (ja) | 1997-12-24 | 2006-10-02 | 新規な抗エストロゲンステロイド、ならびに関連の薬学的組成物および使用法 |
Country Status (14)
Country | Link |
---|---|
US (3) | US6054446A (pt-PT) |
EP (4) | EP1847548A3 (pt-PT) |
JP (4) | JP2001525855A (pt-PT) |
KR (1) | KR100464739B1 (pt-PT) |
CN (2) | CN101130567B (pt-PT) |
AU (1) | AU749597C (pt-PT) |
BR (1) | BR9814435A (pt-PT) |
CA (1) | CA2281844C (pt-PT) |
DE (2) | DE69839893D1 (pt-PT) |
HU (1) | HUP0100136A3 (pt-PT) |
IL (1) | IL136972A0 (pt-PT) |
NO (1) | NO317978B1 (pt-PT) |
RU (1) | RU2233288C2 (pt-PT) |
WO (1) | WO1999033859A2 (pt-PT) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
WO2001012206A2 (de) * | 1999-08-13 | 2001-02-22 | Heinrich Wieland | Soja-glycine extracten und aromatase-hemendern zur positiven beeinflussung von kollagen |
US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
AUPQ342599A0 (en) * | 1999-10-14 | 1999-11-04 | University Of Melbourne, The | Conjugates and uses thereof |
WO2001058919A2 (en) * | 2000-02-11 | 2001-08-16 | Sri International | Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one |
JPWO2001081364A1 (ja) | 2000-04-24 | 2004-01-08 | 協和醗酵工業株式会社 | エストラ−1,3,5(10)−トリエン誘導体 |
AU2001269953A1 (en) * | 2000-06-20 | 2002-01-02 | United States Postal Service | Systems and methods for electronic message content identification |
US6995278B2 (en) | 2000-08-18 | 2006-02-07 | Entre Med, Inc. | Antiangiogenic agents |
US7135581B2 (en) | 2000-08-18 | 2006-11-14 | Entremed, Inc. | Antiangiogenic agents |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
EP1330467B1 (en) * | 2000-11-03 | 2007-05-02 | Washington University | Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
WO2002042319A2 (en) * | 2000-11-27 | 2002-05-30 | Entremed, Inc. | 2-substituted estrogens as antiangiogenic agents |
JP2002241395A (ja) * | 2001-02-16 | 2002-08-28 | Taiho Yakuhin Kogyo Kk | エストラ−4,6−ジエン−3,17−ジオンの製造方法 |
EP1450839A4 (en) * | 2001-11-06 | 2009-06-24 | Serono Lab | METHOD OF TREATING BREAST CANCER THAT MEETS OESTROGENES |
CA2466106A1 (en) * | 2001-11-06 | 2003-05-15 | Applied Research Systems Ars Holding N.V. | Methods of treating endometreosis |
DE60330749D1 (de) * | 2002-01-21 | 2010-02-11 | Organon Nv | Verfahren zur herstellung von 7-alpha-methylsteroide |
DE10307103A1 (de) | 2003-02-19 | 2004-09-09 | Schering Ag | Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate |
CA2536946A1 (en) * | 2003-08-26 | 2005-03-03 | Board Of Regents, The University Of Texas System | Estrogen receptor modulators and uses thereof |
JP2007529426A (ja) | 2004-03-12 | 2007-10-25 | エントレメッド インコーポレイテッド | 抗血管新生薬 |
US20060264413A1 (en) * | 2005-04-18 | 2006-11-23 | Sri International | Method and composition for inhibiting cell proliferation and angiogenesis |
DE202006021081U1 (de) * | 2005-07-12 | 2012-05-08 | Dmi Biosciences, Inc. | Produkte zur Behandlung von Krankheiten |
TW200740442A (en) | 2005-08-29 | 2007-11-01 | Taiho Pharmaceutical Co Ltd | Therapeutic agent for hypertension |
WO2007049672A1 (ja) | 2005-10-27 | 2007-05-03 | Taiho Pharmaceutical Co., Ltd. | ステロイド化合物の製造法 |
AU2007227256B2 (en) | 2006-03-20 | 2012-10-04 | Entremed, Inc. | Disease modifying anti-arthritic activity of 2-methoxyestradiol |
CA2702710C (en) | 2007-10-16 | 2013-05-07 | Repros Therapeutics, Inc. | Trans-clomiphene for metabolic syndrome |
AU2010264524B2 (en) | 2009-06-22 | 2015-03-19 | Ampio Pharmaceuticals, Inc. | Method for treatment of diseases |
WO2011133475A2 (en) * | 2010-04-19 | 2011-10-27 | Sri International | Compositions and method for the treatment of multiple myeloma |
BR112012032189B1 (pt) | 2010-06-16 | 2020-11-03 | Endorecherche, Inc | usos de um agonista ou antagonista de lhrh em associação com um modulador de receptor de estrogênio seletivo e com um precursor de esteróide sexual para a preparação de uma medicamento para o tratamento ou prevenção de doenças relacionadas com estrogênio e kits |
WO2013071214A1 (en) * | 2011-11-10 | 2013-05-16 | Sri International | Synergistic anti-cancer activity of sr16388 with anti-mitotic drugs |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
CA2865234A1 (en) | 2012-02-29 | 2013-09-06 | Repros Therapeutics Inc. | Combination therapy for treating androgen deficiency |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
AU2013361338A1 (en) | 2012-12-19 | 2015-08-06 | Ampio Pharmaceuticals, Inc. | Method for treatment of diseases |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
CN108348531A (zh) | 2015-07-14 | 2018-07-31 | 耐贝医药株式会社 | 具有雌激素受体α抑制作用的雌激素受体β部分激动剂及使用该雌激素受体β部分激动剂的妇科疾病治疗剂 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
AU2016352592B2 (en) | 2015-11-10 | 2023-04-27 | Paracrine Therapeutics Ab | Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen |
US20170157143A1 (en) * | 2015-12-02 | 2017-06-08 | Helix Twelve Pharmaceuticals Corporation, Inc. | Norpregnane derivatives for the risk reduction of breast cancer |
CA3020153A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
CN107805247B (zh) * | 2017-10-31 | 2020-09-29 | 上海长征富民金山制药有限公司 | 一种用于制备抗肾纤维化药物和/或抗慢性肾病药的β-咔啉化合物的制备工艺及其应用 |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE84180C (pt-PT) * | ||||
FR943462A (fr) * | 1946-03-08 | 1949-03-09 | Ford | Dispositif d'évacuation de l'eau pour glaces de voiture automobile |
US2666769A (en) * | 1952-09-27 | 1954-01-19 | Searle & Co | 17-glycolyl-estradiols |
US2840581A (en) * | 1956-12-17 | 1958-06-24 | Upjohn Co | Carbonyloxy steroids |
BE634065A (pt-PT) * | 1962-06-25 | 1900-01-01 | ||
FR3031M (fr) | 1963-05-08 | 1964-12-28 | Roussel Uclaf | Nouveau médicament notamment pour le traitement de l'hypercholestérolémie et des troubles en résultant. |
FR1453210A (fr) | 1963-05-08 | 1966-06-03 | Roussel Uclaf | Nouveaux aminostéroïdes et procédé de préparation |
FR3012M (fr) * | 1963-05-13 | 1964-12-21 | Roussel Uclaf | Nouveaux médicaments doués notamment d'activité hypocholestérolémiante. |
US3271426A (en) * | 1963-06-28 | 1966-09-06 | Schering Corp | Novel androstane oximino ethers and methods for their manufacture |
NL125071C (pt-PT) * | 1963-12-24 | |||
FR1512326A (fr) * | 1964-03-27 | 1968-02-09 | Roussel Uclaf | Nouveaux stéroïdes azotés et procédé de préparation |
US3271392A (en) * | 1965-09-14 | 1966-09-06 | American Home Prod | 17alpha-[3'-furyl]-estrogens |
US3318917A (en) * | 1965-11-12 | 1967-05-09 | Searle & Co | 17alpha-(4-alkoxy-3-buten-1-ynyl)estra-1, 3, 5(10)-triene-3, 17beta-diols and derivatives thereof |
US3405147A (en) * | 1966-02-25 | 1968-10-08 | Searle & Co | 17-phenylaliphatylestra-1, 3, 5(10)-trien-3-ols, 16-dehydro derivatives correspondingand esters thereof |
US3398138A (en) * | 1966-05-24 | 1968-08-20 | American Home Prod | Novel cardenolides and derivatives |
US3448126A (en) * | 1967-02-27 | 1969-06-03 | Searle & Co | 3-oxygenated 19-norpregna-1,3,5(10),17(20)-tetraen-21-als and enol esters thereof |
US3536703A (en) * | 1968-09-11 | 1970-10-27 | Searle & Co | N - (3 - alkoxy - 19 - norpregna - 1,3,5(10),17(20) - tetraen - 21 - yl)amines and derivatives thereof |
GB1305752A (pt-PT) * | 1970-03-06 | 1973-02-07 | ||
US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
BE787343A (fr) * | 1971-08-10 | 1973-02-09 | Hoffmann La Roche | Procede pour la preparation de 17-(2-halogenoethylidene)- steroides |
US3927046A (en) * | 1972-12-09 | 1975-12-16 | Akzona Inc | Novel 11,11-alkylidene steroids |
US3859365A (en) * | 1973-07-19 | 1975-01-07 | Eastman Kodak Co | Production of alkyl-substituted phenols from cyclohexenones |
US3946052A (en) * | 1975-06-16 | 1976-03-23 | Stanford Research Institute | 19-Norpregna- 1,3,5(10)-trien-3-ol and loweralkyl homologs thereof having postcoital antifertility activity |
US4705783A (en) * | 1985-06-25 | 1987-11-10 | Sri International | 9α, 11β-substituted and 11β-substituted estranes |
US5274089A (en) * | 1985-10-18 | 1993-12-28 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
EP0243449A1 (en) * | 1985-10-18 | 1987-11-04 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
US5371078A (en) * | 1988-10-31 | 1994-12-06 | Alcon Laboratories, Inc. | Angiostatic steroids and methods and compositions for controlling ocular hypertension |
US4882319A (en) * | 1988-12-23 | 1989-11-21 | Smithkline Beckman Corporation | Phosphonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase |
DE3925507A1 (de) * | 1989-07-28 | 1991-01-31 | Schering Ag | 14,17(alpha)-etheno- und ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln |
DE69128820T2 (de) * | 1990-08-14 | 1998-06-10 | Hoechst Marion Roussel Inc | Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon |
DE4132182A1 (de) * | 1991-09-24 | 1993-03-25 | Schering Ag | 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln |
FR2685332A1 (fr) * | 1991-12-20 | 1993-06-25 | Roussel Uclaf | Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments. |
EP0633881B1 (en) | 1992-03-11 | 2003-10-29 | Narhex Limited | Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
TW303299B (pt-PT) | 1993-07-22 | 1997-04-21 | Lilly Co Eli | |
US5554603A (en) * | 1993-09-17 | 1996-09-10 | The United States Of America As Represented By The Department Of Health And Human Services | Orally active derivatives of 1,3,5(10)-estratriene |
JPH07101977A (ja) * | 1993-10-05 | 1995-04-18 | Kureha Chem Ind Co Ltd | ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤 |
US5578613A (en) | 1993-12-21 | 1996-11-26 | Eli Lilly And Company | Methods for inhibiting weight gain or inducing weight loss |
US6417198B1 (en) | 1993-12-21 | 2002-07-09 | Eli Lilly And Company | Methods of inhibiting CNS problems in post-menopausal women |
US5447941A (en) | 1993-12-21 | 1995-09-05 | Eli Lilly And Company | Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes |
US5451589A (en) | 1993-12-21 | 1995-09-19 | Eli Lilly And Company | Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism |
US5446053A (en) | 1993-12-21 | 1995-08-29 | Eli Lilly And Company | Methods of inhibiting dysfunctional uterine bleeding |
US5461064A (en) | 1993-12-21 | 1995-10-24 | Eli Lilly And Company | Methods of inhibiting atrophy of the skin and vagina |
US5593987A (en) | 1993-12-21 | 1997-01-14 | Eli Lilly And Company | Methods of inhibiting breast disorders |
US5591753A (en) | 1994-01-28 | 1997-01-07 | Eli Lilly And Company | Combination treatment for osteoporosis |
US5478847A (en) | 1994-03-02 | 1995-12-26 | Eli Lilly And Company | Methods of use for inhibiting bone loss and lowering serum cholesterol |
FR2718138B1 (fr) * | 1994-04-01 | 1996-04-26 | Roussel Uclaf | Nouveaux stéroïdes comportant en position 20 une chaîne aminosubstituée, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les renfermant. |
US5612317A (en) * | 1994-08-04 | 1997-03-18 | Holick; Michael F. | Method for delivering estrogen |
GB9518858D0 (en) * | 1995-09-14 | 1995-11-15 | Pharmacia Spa | Phenylsubstituted 4-azasteroid fluoroderivatives |
US5843904A (en) * | 1995-12-20 | 1998-12-01 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1βconverting enzyme |
US5866560A (en) * | 1996-08-20 | 1999-02-02 | Schering Ag | 7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents |
DE19635525A1 (de) * | 1996-08-20 | 1998-02-26 | Schering Ag | 7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
US5945412A (en) * | 1996-12-09 | 1999-08-31 | Merck & Co., Inc. | Methods and compositions for preventing and treating bone loss |
RU58668U1 (ru) | 2006-06-05 | 2006-11-27 | Открытое акционерное общество "Нижегородский машиностроительный завод" | Водогрейный котел |
-
1997
- 1997-12-24 US US08/998,877 patent/US6054446A/en not_active Expired - Lifetime
-
1998
- 1998-12-23 CA CA002281844A patent/CA2281844C/en not_active Expired - Fee Related
- 1998-12-23 HU HU0100136A patent/HUP0100136A3/hu unknown
- 1998-12-23 BR BR9814435-9A patent/BR9814435A/pt not_active Application Discontinuation
- 1998-12-23 DE DE69839893T patent/DE69839893D1/de not_active Expired - Lifetime
- 1998-12-23 CN CN200710128699XA patent/CN101130567B/zh not_active Expired - Lifetime
- 1998-12-23 IL IL13697298A patent/IL136972A0/xx not_active IP Right Cessation
- 1998-12-23 JP JP53517299A patent/JP2001525855A/ja not_active Withdrawn
- 1998-12-23 EP EP07015863A patent/EP1847548A3/en not_active Withdrawn
- 1998-12-23 EP EP03000183A patent/EP1310509B1/en not_active Expired - Lifetime
- 1998-12-23 KR KR10-1999-7007640A patent/KR100464739B1/ko not_active IP Right Cessation
- 1998-12-23 EP EP98964882A patent/EP1056768B1/en not_active Expired - Lifetime
- 1998-12-23 EP EP10177213.5A patent/EP2305694A3/en not_active Withdrawn
- 1998-12-23 WO PCT/US1998/027406 patent/WO1999033859A2/en active IP Right Grant
- 1998-12-23 CN CNB988137011A patent/CN1332974C/zh not_active Expired - Fee Related
- 1998-12-23 RU RU2000116270/04A patent/RU2233288C2/ru not_active IP Right Cessation
- 1998-12-23 AU AU20104/99A patent/AU749597C/en not_active Ceased
- 1998-12-23 DE DE69812433T patent/DE69812433T2/de not_active Expired - Lifetime
- 1998-12-24 US US09/220,408 patent/US6281205B1/en not_active Expired - Lifetime
-
2000
- 2000-06-22 NO NO20003254A patent/NO317978B1/no not_active IP Right Cessation
-
2001
- 2001-07-30 US US09/918,890 patent/US6455517B1/en not_active Expired - Lifetime
-
2006
- 2006-10-02 JP JP2006271306A patent/JP4959276B2/ja not_active Expired - Lifetime
- 2006-10-02 JP JP2006271307A patent/JP3968114B2/ja not_active Expired - Fee Related
-
2007
- 2007-05-01 JP JP2007121321A patent/JP4718512B2/ja not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007269797A5 (pt-PT) | ||
CA2124932C (en) | Sex steroid activity inhibitors | |
JP2011507878A5 (pt-PT) | ||
JP2007518767A5 (pt-PT) | ||
JP2017125036A (ja) | アンドロゲン受容体調節薬のエステル誘導体およびそれらの使用のための方法 | |
RU2006129312A (ru) | Производные ариланилина в качестве агонистов 2 адренергического рецептора | |
KR20080034436A (ko) | 암 치료에 사용되는 티아졸 유도체 및 유사체 | |
JP2016502519A (ja) | Hbv集合エフェクターの代替的使用 | |
RU2010126063A (ru) | Производные 4-(2-амино-1-гидроксиэтил)фенола как агонисты в2 адренергического рецептора | |
JP2006507220A5 (pt-PT) | ||
RU2009104764A (ru) | Производные пурина, как антангонисты a2a | |
BR112017005111B1 (pt) | Compostos análogos de nucleotídeo acíclico, composição farmacêutica contendo tais compostos, e usos da composição no tratamento de uma infecção por papilomavírus | |
JP2013541503A5 (pt-PT) | ||
CN104797565A (zh) | 新的苯磺酰胺噻唑化合物 | |
RU2012110380A (ru) | Новое производное 5-фторурацила | |
RU2010113358A (ru) | Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов | |
JP2005511545A5 (pt-PT) | ||
JP2008542386A5 (pt-PT) | ||
EP3733665A1 (en) | Nitrogen-containing six-membered ring compound | |
JP2010505898A (ja) | エストロゲン受容体リガンドとして有用な2−フェニルインデン誘導体 | |
WO2020139960A1 (en) | Galectin-3 inhibiting c-glycosides | |
JP2022522312A (ja) | ピロール化合物 | |
JP2009533392A5 (pt-PT) | ||
JP2005526773A5 (pt-PT) | ||
WO2005058934A2 (en) | Glycosylated steroid derivatives with anti-migratory activity |